• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cano Health Announces Date to Report Fourth Quarter and Full Year 2022 Results and Participation in Upcoming Investor Conference

    2/21/23 4:31:00 PM ET
    $CANO
    Medical/Nursing Services
    Health Care
    Get the next $CANO alert in real time by email

    MIAMI, Feb. 21, 2023 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE:CANO), a leading value-based primary care provider and population health company, will release its financial results for the fourth quarter and full year 2022 after the market closes on Wednesday, March 1, 2023, and will host a conference call at 5:00 PM Eastern Time the same day to review its business and financial results. 

    (PRNewsfoto/Cano Health, LLC)

    To access the live call and webcast, please dial (888) 660-6359 for U.S. participants, or (929) 203-0867 for international participants, referencing the Cano Health Fourth Quarter 2022 Earnings Conference Call and Conference ID 8371699.  The call will also be webcast live in the "Events & Presentations" section of Cano Health's Investor Relations website (investors.canohealth.com).  A replay will be available in the same section of the Cano Health website for on-demand listening shortly after the completion of the call and will be available for 30 days.

    In addition, Cano Health executives will participate in the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023, in Boston, MA.  Dr. Marlow Hernandez, Chairman and Chief Executive Officer, and Brian Koppy, Chief Financial Officer, will participate in a fireside chat at 9:50 AM Eastern Time.

    A live webcast of the fireside chat will be accessible through Cano Health's Investor Relations website at investors.canohealth.com.  The webcast will be archived for replay following the conference.

    About Cano Health 

    Cano Health (NYSE:CANO) is a high-touch, technology-powered healthcare company delivering personalized, value-based primary care to approximately 300,000 members.  With its headquarters in Miami, Florida, Cano Health is transforming healthcare by delivering primary care that measurably improves the health, wellness, and quality of life of its patients and the communities it serves.  Founded in 2009, Cano Health has more than 4,000 employees, and operates primary care medical centers and supports affiliated providers in nine states and Puerto Rico.  For more information, visit canohealth.com or investors.canohealth.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cano-health-announces-date-to-report-fourth-quarter-and-full-year-2022-results-and-participation-in-upcoming-investor-conference-301752344.html

    SOURCE Cano Health, Inc.

    Get the next $CANO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CANO

    DatePrice TargetRatingAnalyst
    8/11/2023Buy → Hold
    Jefferies
    8/11/2023$4.00 → $0.80Buy → Neutral
    Citigroup
    1/6/2023$12.00 → $1.25Buy → Neutral
    UBS
    1/5/2023Outperform → Peer Perform
    Wolfe Research
    12/13/2022$1.50Underperform
    BofA Securities
    11/10/2022$10.00 → $3.00Outperform → Market Perform
    Cowen
    11/10/2022Outperform → Mkt Perform
    Raymond James
    10/27/2022$10.00 → $5.00Outperform → Neutral
    Credit Suisse
    More analyst ratings

    $CANO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Cooperstone Elliot sold $60,243 worth of shares (22,738 units at $2.65) (SEC Form 4)

      4 - Cano Health, Inc. (0001800682) (Issuer)

      2/2/24 6:56:35 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cooperstone Elliot sold $251,167 worth of shares (92,619 units at $2.71) (SEC Form 4)

      4 - Cano Health, Inc. (0001800682) (Issuer)

      1/29/24 8:07:21 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cooperstone Elliot sold $629,175 worth of shares (233,842 units at $2.69) (SEC Form 4)

      4 - Cano Health, Inc. (0001800682) (Issuer)

      1/24/24 8:07:45 PM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan

      Emergence from Chapter 11 Expected in Third Quarter of 2024 MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's general unsecured creditors, with the support of the Ad Hoc Lender Group. It also received approval of its Disclosure Statement by the U.S. Bankruptcy Court for the District of Delaware (the "Court"), paving the way to solicit creditor approval of its Plan of Reorganization and its expected emergence from Chapter 11 in the third quarter. Mark

      5/21/24 5:04:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings

      MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company's Class A common stock, par value $0.01 per share ("Common Stock") and (b) immediately suspend trading in the Company's Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024.

      2/5/24 4:35:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position

      Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow Receives Commitment for $150 Million in New Capital Ensures Patients Continue to Receive High-Quality Care Across Medical Centers MIAMI, Feb. 4, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has entered into a Restructuring Support Agreement (the "RSA") with lenders (the "Ad Hoc Lender Group") holding approximately 86% of its secured revolving and term loan debt and 92% of its senior unsecured notes. This a

      2/4/24 11:57:00 PM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    SEC Filings

    See more
    • Cano Health Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - Cano Health, Inc. (0001800682) (Filer)

      2/9/24 9:34:53 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - Cano Health, Inc. (0001800682) (Filer)

      2/7/24 5:18:05 PM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • SEC Form 25-NSE filed by Cano Health Inc.

      25-NSE - Cano Health, Inc. (0001800682) (Subject)

      2/6/24 9:27:20 AM ET
      $CANO
      Medical/Nursing Services
      Health Care

    $CANO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cano Health downgraded by Jefferies

      Jefferies downgraded Cano Health from Buy to Hold

      8/11/23 10:23:10 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health downgraded by Citigroup with a new price target

      Citigroup downgraded Cano Health from Buy to Neutral and set a new price target of $0.80 from $4.00 previously

      8/11/23 7:12:10 AM ET
      $CANO
      Medical/Nursing Services
      Health Care
    • Cano Health downgraded by UBS with a new price target

      UBS downgraded Cano Health from Buy to Neutral and set a new price target of $1.25 from $12.00 previously

      1/6/23 8:53:28 AM ET
      $CANO
      Medical/Nursing Services
      Health Care